🔎 Trials Near Me

Home › Ewing Sarcoma › Texas

Pag-aaral pangklinika para sa Ewing Sarcoma sa Texas

10 pag-aaral para sa Ewing Sarcoma ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Children's Medical Center, Dallas
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06541262

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

  • The University of Texas MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
Edad 16 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07197554

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Children's Health Dallas, Dallas
  • The University of Texas MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1/2
Edad 2 hanggang 30 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT05734066

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • University of Texas MD Anderson Cancer Center ( Site 1007), Houston
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06395103

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

  • University of Texas MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
Edad 2 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07297979

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

  • UT Southwestern, Dallas
  • Texas Tech University Health Sciences Center, Lubbock
Nagre-recruitPhase 1
12 Months – 20 Years · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT02013336

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • UT MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
Edad 12 hanggang 85 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT03715933

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • Children's Medical Center, Dallas
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

  • Texas Children's Hospital, Houston
Nagre-recruitPhase 1
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT04995003

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.